Skip to main content
Erschienen in: Tumor Biology 12/2014

01.12.2014 | Research Article

RETRACTED ARTICLE: Association of androgen receptor exon 1 CAG repeat length with risk of hepatocellular carcinoma: a case–control study

verfasst von: Kainan Li, Chen Zhong, Jun Wang, Baocheng Wang, Jun He, Jingwang Bi

Erschienen in: Tumor Biology | Ausgabe 12/2014

Einloggen, um Zugang zu erhalten

Abstract

Epidemiologic and biological data suggest a role for androgens and perhaps their receptor in hepatocellular carcinoma (HCC) development. However, few studies evaluated an association between HCC risk and androgen receptor (AR) cytosine, adenine, guanine (CAG) repeat length. To examine whether the relationship between the AR CAG repeats and HCC risk was also evident in Chinese, we conducted this large population-based, case–control study of 2,000 pathologically confirmed HCC patients and 2,000 frequency-matched controls. Two different approaches for AR CAG repeat length (analyses with continuous and categorized polymorphism variables) were conducted in the statistical analyses. For AR CAG longer allele (CAG_L), we found that subjects with longer AR CAG_L repeats had a decreased risk of developing HCC (OR = 0.87 for per CAG_A increase, 95 % CI 0.82–0.96, P = 5.33 × 10−4). Compared to those with the shorter (<23) CAG_L repeat length, subjects in the category of longer (≥23) CAG_L repeats had a significant 20 % decreased HCC risk (OR = 0.80, 95 % CI 0.71–0.91, P = 6.16 × 10−4). These findings suggest that androgen signaling underlies the development of HCC.
Literatur
1.
Zurück zum Zitat Mourad A, Deuffic-Burban S, Ganne-Carrie N, Renaut-Vantroys T, Rosa I, Bouvier AM, et al. Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: a modeling approach. Hepatology. 2014;59:1471–81.CrossRef Mourad A, Deuffic-Burban S, Ganne-Carrie N, Renaut-Vantroys T, Rosa I, Bouvier AM, et al. Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: a modeling approach. Hepatology. 2014;59:1471–81.CrossRef
2.
Zurück zum Zitat Deng Y, Li M, Wang J, Xie L, Li T, He Y, Lu Q, Li R, Tan A, Qin X, Li S: Susceptibility to hepatocellular carcinoma in the Chinese population-associations with interleukin-6 receptor polymorphism. Tumour Biol 2014 Deng Y, Li M, Wang J, Xie L, Li T, He Y, Lu Q, Li R, Tan A, Qin X, Li S: Susceptibility to hepatocellular carcinoma in the Chinese population-associations with interleukin-6 receptor polymorphism. Tumour Biol 2014
3.
Zurück zum Zitat Long XD, Zhao D, Wang C, Huang XY, Yao JG, Ma Y, et al. Genetic polymorphisms in DNA repair genes XRCC4 and XRCC5 and aflatoxin B1-related hepatocellular carcinoma. Epidemiology. 2013;24:671–81.CrossRef Long XD, Zhao D, Wang C, Huang XY, Yao JG, Ma Y, et al. Genetic polymorphisms in DNA repair genes XRCC4 and XRCC5 and aflatoxin B1-related hepatocellular carcinoma. Epidemiology. 2013;24:671–81.CrossRef
4.
Zurück zum Zitat Song P. Standardizing management of hepatocellular carcinoma in China: devising evidence-based clinical practice guidelines. Biosci Trends. 2013;7:250–2.PubMed Song P. Standardizing management of hepatocellular carcinoma in China: devising evidence-based clinical practice guidelines. Biosci Trends. 2013;7:250–2.PubMed
5.
Zurück zum Zitat Zheng J, Li C, Wu X, Yang Y, Hao M, Sheng S, et al. Astrocyte elevated gene-1 is a novel biomarker of epithelial-mesenchymal transition and progression of hepatocellular carcinoma in two China regions. Tumour Biol. 2014;35:2265–9.CrossRef Zheng J, Li C, Wu X, Yang Y, Hao M, Sheng S, et al. Astrocyte elevated gene-1 is a novel biomarker of epithelial-mesenchymal transition and progression of hepatocellular carcinoma in two China regions. Tumour Biol. 2014;35:2265–9.CrossRef
6.
Zurück zum Zitat Song P, Gao J, Inagaki Y, Kokudo N, Hasegawa K, Sugawara Y, et al. Biomarkers: evaluation of screening for and early diagnosis of hepatocellular carcinoma in Japan and China. Liver Cancer. 2013;2:31–9.CrossRef Song P, Gao J, Inagaki Y, Kokudo N, Hasegawa K, Sugawara Y, et al. Biomarkers: evaluation of screening for and early diagnosis of hepatocellular carcinoma in Japan and China. Liver Cancer. 2013;2:31–9.CrossRef
7.
Zurück zum Zitat Wu J, Zhang W, Xu A, Zhang L, Yan T, Li Z, et al. Association of epidermal growth factor and epidermal growth factor receptor polymorphisms with the risk of hepatitis B virus-related hepatocellular carcinoma in the population of North China. Genet Test Mol Biomarkers. 2013;17:595–600.CrossRef Wu J, Zhang W, Xu A, Zhang L, Yan T, Li Z, et al. Association of epidermal growth factor and epidermal growth factor receptor polymorphisms with the risk of hepatitis B virus-related hepatocellular carcinoma in the population of North China. Genet Test Mol Biomarkers. 2013;17:595–600.CrossRef
8.
Zurück zum Zitat Naveed M, Waljee AK, Singal AG: Predictive models for hepatocellular carcinoma. Gastroenterology 2014. Naveed M, Waljee AK, Singal AG: Predictive models for hepatocellular carcinoma. Gastroenterology 2014.
9.
Zurück zum Zitat Yeh SH, Chang CF, Shau WY, Chen YW, Hsu HC, Lee PH, et al. Dominance of functional androgen receptor allele with longer cag repeat in hepatitis B virus-related female hepatocarcinogenesis. Cancer Res. 2002;62:4346–51.PubMed Yeh SH, Chang CF, Shau WY, Chen YW, Hsu HC, Lee PH, et al. Dominance of functional androgen receptor allele with longer cag repeat in hepatitis B virus-related female hepatocarcinogenesis. Cancer Res. 2002;62:4346–51.PubMed
10.
Zurück zum Zitat Toh YC. Effect of neonatal castration on liver tumor induction by n-2-fluorenylacetamide in suckling balb/c mice. Carcinogenesis. 1981;2:1219–21.CrossRef Toh YC. Effect of neonatal castration on liver tumor induction by n-2-fluorenylacetamide in suckling balb/c mice. Carcinogenesis. 1981;2:1219–21.CrossRef
11.
Zurück zum Zitat Firminger HI, Reuber MD. Influence of adrenocortical, androgenic, and anabolic hormones on the development of carcinoma and cirrhosis of the liver in a x c rats fed N-2-fluorenyldicetamide. J Natl Cancer Inst. 1961;27:559–95.PubMed Firminger HI, Reuber MD. Influence of adrenocortical, androgenic, and anabolic hormones on the development of carcinoma and cirrhosis of the liver in a x c rats fed N-2-fluorenyldicetamide. J Natl Cancer Inst. 1961;27:559–95.PubMed
12.
Zurück zum Zitat Granata OM, Cocciadifero L, Campisi I, Miceli V, Montalto G, Polito LM, et al. Androgen metabolism and biotransformation in nontumoral and malignant human liver tissues and cells. J Steroid Biochem Mol Biol. 2009;113:290–5.CrossRef Granata OM, Cocciadifero L, Campisi I, Miceli V, Montalto G, Polito LM, et al. Androgen metabolism and biotransformation in nontumoral and malignant human liver tissues and cells. J Steroid Biochem Mol Biol. 2009;113:290–5.CrossRef
13.
Zurück zum Zitat Liang L, Lu M, Huang J. Androgen receptor in hepatocellular carcinoma and the surrounding liver tissues in China. Zhonghua Zhong Liu Za Zhi. 1996;18:214–7.PubMed Liang L, Lu M, Huang J. Androgen receptor in hepatocellular carcinoma and the surrounding liver tissues in China. Zhonghua Zhong Liu Za Zhi. 1996;18:214–7.PubMed
14.
Zurück zum Zitat Abdelgadir SE, Connolly PB, Resko JA. Androgen binding in peripheral tissues of fetal rhesus macaques: effects of androgen metabolism in liver. J Steroid Biochem Mol Biol. 1990;37:545–51.CrossRef Abdelgadir SE, Connolly PB, Resko JA. Androgen binding in peripheral tissues of fetal rhesus macaques: effects of androgen metabolism in liver. J Steroid Biochem Mol Biol. 1990;37:545–51.CrossRef
15.
Zurück zum Zitat Davies HR, Hughes IA, Patterson MN. Genetic counselling in complete androgen insensitivity syndrome: trinucleotide repeat polymorphisms, single-strand conformation polymorphism and direct detection of two novel mutations in the androgen receptor gene. Clin Endocrinol (Oxf). 1995;43:69–77.CrossRef Davies HR, Hughes IA, Patterson MN. Genetic counselling in complete androgen insensitivity syndrome: trinucleotide repeat polymorphisms, single-strand conformation polymorphism and direct detection of two novel mutations in the androgen receptor gene. Clin Endocrinol (Oxf). 1995;43:69–77.CrossRef
16.
Zurück zum Zitat Sleddens HF, Oostra BA, Brinkmann AO, Trapman J. Trinucleotide (ggn) repeat polymorphism in the human androgen receptor (AR) gene. Hum Mol Genet. 1993;2:493.CrossRef Sleddens HF, Oostra BA, Brinkmann AO, Trapman J. Trinucleotide (ggn) repeat polymorphism in the human androgen receptor (AR) gene. Hum Mol Genet. 1993;2:493.CrossRef
17.
Zurück zum Zitat Sleddens HF, Oostra BA, Brinkmann AO, Trapman J. Trinucleotide repeat polymorphism in the androgen receptor gene (AR). Nucleic Acids Res. 1992;20:1427.CrossRef Sleddens HF, Oostra BA, Brinkmann AO, Trapman J. Trinucleotide repeat polymorphism in the androgen receptor gene (AR). Nucleic Acids Res. 1992;20:1427.CrossRef
18.
Zurück zum Zitat Schildkraut JM, Murphy SK, Palmieri RT, Iversen E, Moorman PG, Huang Z, et al. Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:473–80.CrossRef Schildkraut JM, Murphy SK, Palmieri RT, Iversen E, Moorman PG, Huang Z, et al. Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:473–80.CrossRef
19.
Zurück zum Zitat Yu MW, Yang YC, Yang SY, Chang HC, Liaw YF, Lin SM, et al. Androgen receptor exon 1 cag repeat length and risk of hepatocellular carcinoma in women. Hepatology. 2002;36:156–63.CrossRef Yu MW, Yang YC, Yang SY, Chang HC, Liaw YF, Lin SM, et al. Androgen receptor exon 1 cag repeat length and risk of hepatocellular carcinoma in women. Hepatology. 2002;36:156–63.CrossRef
20.
Zurück zum Zitat Yu MW, Cheng SW, Lin MW, Yang SY, Liaw YF, Chang HC, et al. Androgen-receptor gene cag repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst. 2000;92:2023–8.CrossRef Yu MW, Cheng SW, Lin MW, Yang SY, Liaw YF, Chang HC, et al. Androgen-receptor gene cag repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst. 2000;92:2023–8.CrossRef
21.
Zurück zum Zitat Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153–6.CrossRef Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153–6.CrossRef
22.
Zurück zum Zitat Chang C, Lee SO, Yeh S, Chang TM. Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver. Oncogene. 2014;33:3225–34.CrossRef Chang C, Lee SO, Yeh S, Chang TM. Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver. Oncogene. 2014;33:3225–34.CrossRef
23.
Zurück zum Zitat Gao B, Jiang L, Kunos G. Transcriptional regulation of alpha(1b) adrenergic receptors (alpha(1b)AR) by nuclear factor 1 (nf1): a decline in the concentration of nf1 correlates with the downregulation of alpha(1b)AR gene expression in regenerating liver. Mol Cell Biol. 1996;16:5997–6008.CrossRef Gao B, Jiang L, Kunos G. Transcriptional regulation of alpha(1b) adrenergic receptors (alpha(1b)AR) by nuclear factor 1 (nf1): a decline in the concentration of nf1 correlates with the downregulation of alpha(1b)AR gene expression in regenerating liver. Mol Cell Biol. 1996;16:5997–6008.CrossRef
24.
Zurück zum Zitat Langner A, Nerlich C, Grahlmann D. Biotransformation of the trapidil (Rocornal) derivative AR 12,463 by the isolated, perfused rat liver and rat hepatocyte suspension cultures. Die Pharmazie. 1990;45:636.PubMed Langner A, Nerlich C, Grahlmann D. Biotransformation of the trapidil (Rocornal) derivative AR 12,463 by the isolated, perfused rat liver and rat hepatocyte suspension cultures. Die Pharmazie. 1990;45:636.PubMed
25.
Zurück zum Zitat Clark PE, Irvine RA, Coetzee GA. The androgen receptor cag repeat and prostate cancer risk. Methods Mol Med. 2003;81:255–66.PubMed Clark PE, Irvine RA, Coetzee GA. The androgen receptor cag repeat and prostate cancer risk. Methods Mol Med. 2003;81:255–66.PubMed
26.
Zurück zum Zitat Hsing AW, Gao YT, Wu G, Wang X, Deng J, Chen YL, et al. Polymorphic cag and ggn repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China. Cancer Res. 2000;60:5111–6.PubMed Hsing AW, Gao YT, Wu G, Wang X, Deng J, Chen YL, et al. Polymorphic cag and ggn repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China. Cancer Res. 2000;60:5111–6.PubMed
27.
Zurück zum Zitat Yeh SH, Chiu CM, Chen CL, Lu SF, Hsu HC, Chen DS, et al. Somatic mutations at the trinucleotide repeats of androgen receptor gene in male hepatocellular carcinoma. Int J Cancer. 2007;120:1610–7.CrossRef Yeh SH, Chiu CM, Chen CL, Lu SF, Hsu HC, Chen DS, et al. Somatic mutations at the trinucleotide repeats of androgen receptor gene in male hepatocellular carcinoma. Int J Cancer. 2007;120:1610–7.CrossRef
28.
Zurück zum Zitat Ferro P, Catalano MG, Dell’Eva R, Fortunati N, Pfeffer U. The androgen receptor cag repeat: a modifier of carcinogenesis? Mol Cell Endocrinol. 2002;193:109–20.CrossRef Ferro P, Catalano MG, Dell’Eva R, Fortunati N, Pfeffer U. The androgen receptor cag repeat: a modifier of carcinogenesis? Mol Cell Endocrinol. 2002;193:109–20.CrossRef
29.
Zurück zum Zitat Chamberlain NL, Driver ED, Miesfeld RL. The length and location of cag trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res. 1994;22:3181–6.CrossRef Chamberlain NL, Driver ED, Miesfeld RL. The length and location of cag trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res. 1994;22:3181–6.CrossRef
Metadaten
Titel
RETRACTED ARTICLE: Association of androgen receptor exon 1 CAG repeat length with risk of hepatocellular carcinoma: a case–control study
verfasst von
Kainan Li
Chen Zhong
Jun Wang
Baocheng Wang
Jun He
Jingwang Bi
Publikationsdatum
01.12.2014
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 12/2014
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-2570-0

Weitere Artikel der Ausgabe 12/2014

Tumor Biology 12/2014 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.